Thursday, 18 April 2024

[the_ad_group id="2845"]

Business News

Diagnos Inc Grants Stock Options to Director – TipRanks Financial Blog

Apellis downgraded to Hold at Jefferies after doctor survey

[the_ad id="21475"]


Diagnos Inc (TSE:ADK) has released an update.

Diagnos Inc., a Canadian AI tech firm specializing in early detection of health issues, has granted 250,000 stock options to director Philippe Couillard, exercisable at $0.32 per share until 2029. The options vest annually at a rate of 50%, starting from the first anniversary of the grant. This move could signal a strengthening of the company’s governance and commitment to its AI-driven health solutions.

For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.

Click Here to Read the Full Original Article at TipRanks Financial Blog…


[the_ad id="21476"]